l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with omeprazole in 2 studies
Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (omeprazole) | Trials (omeprazole) | Recent Studies (post-2010) (omeprazole) |
---|---|---|---|---|---|
138 | 7 | 2 | 9,085 | 2,737 | 1,487 |
Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | omeprazole (IC50) |
---|---|---|---|
Mcl-1 | Homo sapiens (human) | 3.1448 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.28 | |
Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 1.45 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 2.315 | |
Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 1.45 | |
WD repeat-containing protein 5 | Homo sapiens (human) | 1.7 | |
Glutathione S-transferase omega-1 | Homo sapiens (human) | 4.6 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 1.7 | |
Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | 3.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Taché, Y; Yoneda, M | 1 |
Itoh, M; Joh, T; Kaneko, H; Kataoka, H; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Sobue, M; Suzuki, H; Takahashi, N; Watanabe, K | 1 |
2 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and omeprazole
Article | Year |
---|---|
Vagal regulation of gastric prostaglandin E2 release by central TRH in rats.
Topics: Animals; Brain; Dinoprostone; Extracellular Space; Gastric Acid; Gastric Mucosa; Indomethacin; Injections, Intraventricular; Male; Omeprazole; Pyrrolidonecarboxylic Acid; Rats; Thyrotropin-Releasing Hormone; Vagotomy; Vagus Nerve | 1993 |
Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
Topics: Animals; Anti-Ulcer Agents; Atropine; Brain; Gastric Mucosa; Hydrochloric Acid; Injections, Intraventricular; Male; Muscarinic Antagonists; Omeprazole; Permeability; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Thyrotropin-Releasing Hormone; Vagotomy | 2005 |